Clinical Trials Directory

Trials / Completed

CompletedNCT05745662

Accuracy of Pulse Oximeters With Profound Hypoxia At Rest (NIHO17)

Determination of SpO2 and PR Accuracy Specifications at Rest / Accuracy of Pulse Oximeters With Profound Hypoxia / Pulse Oximeter Accuracy Evaluation Protocol

Status
Completed
Phase
Study type
Observational
Enrollment
11 (actual)
Sponsor
Nihon Kohden · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to determine the accuracy of devices called pulse oximeters, which measure blood oxygen by shining light through fingers, ears or other skin, without requiring blood sampling. Study will be used with patients at rest.

Detailed description

This study is intended to evaluate performance of a new design pulse oximeter (test device) manufactured by Nihon Kohden Corporation sufficiently to support performance claims for an FDA 510K submission or ISO technical file. Specifically, SpO2 and pulse rate accuracy will be assessed for a Nihon Kohden OLV-4202 pulse oximeter with adult patients under a controlled setting of varying levels of inhaled oxygen concentration levels for patients at rest.

Conditions

Interventions

TypeNameDescription
DEVICEPulse OximeterOLV-4202 pulse oximeter (SW version: 01-15)

Timeline

Start date
2023-01-26
Primary completion
2023-02-02
Completion
2024-04-17
First posted
2023-02-27
Last updated
2025-09-12
Results posted
2024-12-24

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05745662. Inclusion in this directory is not an endorsement.